Development and Validation of the Migraine‐Specific Quality of Life Questionnaire

Linking Clinical Variables With Health-Related Quality of Life: A Conceptual Model of Patient Outcomes

Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Juniper, E. F., Guyatt, G. H., Epstein, R. S., Ferrie, P. J., Jaeschke, R., & Hiller, T. K. (1992) · Thorax · doi:10.1136/thx.47.2.76 · Cited by 1,235

Measuring disease-specific quality of life in clinical trials.

Guyatt, G. H., Bombardier, C., & Tugwell, P. (1986) · Europe PMC (PubMed Central) · Cited by 728

Impact of Migraine in the United States: Data from the National Health Interview Survey

Stang, P., & Osterhaus, J. T. (1993) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1993.hed3301029.x · Cited by 335

Measuring the Functional Status and Well‐Being of Patients with Migraine Headache

Osterhaus, J. T., Townsend, R. J., Gandek, B., & Ware, J. E. (1994) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3406337.x · Cited by 325

Quality of Life and Well-Being of Headache Patients: Measurement by the Medical Outcomes Study Instrument

Solomon, G. D., Skobieranda, F. G., & Gragg, L. A. (1993) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1993.hed3307351.x · Cited by 163

Quality of Life Assessment Among Migraine Patients Treated With Sumatriptan

Solomon, G. D., Skobieranda, F. G., & Genzen, J. R. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3508449.x · Cited by 66

The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: A re-analysis of three clinical trials

Kosinski, M. R., Bjørner, J. B., Ware, J. E., Batenhorst, A. S., & Cady, R. K. (2003) · Quality of Life Research · doi:10.1023/a:1026111029376 · Cited by 31

Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Hollier-Hann, G., Curry, A. S., Onishchenko, K., Akehurst, R. L., Ahmed, F., Davies, B., & Keyzor, I. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1675417 · Cited by 30

Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures

Goadsby, P. J., Barbanti, P., Lambru, G., Ettrup, A., Christoffersen, C. L., Josiassen, M. K., Phul, R., & Sperling, B. (2022) · European Journal of Neurology · doi:10.1111/ene.15670 · Cited by 29

Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome

Speck, R. M., Shalhoub, H., Ayer, D. W., Ford, J. H., Wyrwich, K. W., & Bush, E. N. (2019) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-019-0138-x · Cited by 28

A long-term open-label safety study of galcanezumab in Japanese patients with migraine

Hirata, K., Takeshima, T., Sakai, F., Tatsuoka, Y., Suzuki, N., Igarashi, H., Nakamura, T., Ozeki, A., Yamazaki, H., & Skljarevski, V. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1866536 · Cited by 28

Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17–30 months

Troy, E., Shrukalla, A. A., Buture, A., Conaty, K., Macken, E., Lonergan, R., Melling, J., Long, N., Shaikh, E., Birrane, K., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01536-3 · Cited by 28

Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine

Blumenfeld, A. M., Aurora, S. K., Laranjo, K., & Papapetropoulos, S. (2015) · BMC Neurology · doi:10.1186/s12883-015-0353-x · Cited by 28

The impact of comorbid migraine on quality‐of‐life outcomes after endoscopic sinus surgery

DeConde, A. S., Mace, J. C., & Smith, T. L. (2014) · The Laryngoscope · doi:10.1002/lary.24592 · Cited by 27

Measures of Functioning in Patients With Episodic Migraine: Findings From a Double‐Blind, Randomized, Placebo‐Controlled Phase 2b Trial With Galcanezumab

Ayer, D. W., Skljarevski, V., Ford, J. H., Nyhuis, A. W., Lipton, R. B., & Aurora, S. K. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13383 · Cited by 27

Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: A randomised controlled trial protocol (CHESS)

Patel, S., Achana, F., Carnes, D., Eldridge, S., Ellard, D. R., Griffiths, F., Haywood, K., Hee, S. W., Mistry, D., Mistry, H., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033520 · Cited by 24

Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)

Ailani, J., Andrews, J. S., Rettiganti, M. R., & Nicholson, R. A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01190-7 · Cited by 26

Evaluation of the Dutch Version of the Migraine Quality of Life Instrument (Msqol) and Its Application in Headache Coping

Passchier, J., Mourik, J. C., McKenna, S. P., van den Berg, M., & Erdman, R. (2001) · Cephalalgia · doi:10.1046/j.0333-1024.2001.00237.x · Cited by 25

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality‐of‐Life Questionnaire Version 2.1 Electronic Patient‐Reported Outcome in Patients With Episodic and Chronic Migraine

Speck, R. M., Shalhoub, H., Wyrwich, K. W., Yu, R., Ayer, D. W., Ford, J. H., Bush, E. N., & Lipton, R. B. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13497 · Cited by 24

Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double‐blind studies

Ailani, J., Pearlman, E. M., Zhang, Q., Nagy, A. J., Schuh, K. J., & Aurora, S. K. (2019) · European Journal of Neurology · doi:10.1111/ene.14102 · Cited by 24

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

Johnston, K., L'Italien, G. J., Popoff, E., Powell, L. C., Croop, R. S., Thiry, A., Harris, L. A., Coric, V., & Lipton, R. B. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01897-2 · Cited by 24

Pharmacological interventions for acute attacks of vestibular migraine

Webster, K. E., Dor, A., Galbraith, K., Kassem, L. H., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015322.pub2 · Cited by 27

Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)

Ford, J. H., Tassorelli, C., Leroux, É., Wang, S., Ayer, D. W., Nichols, R., & Detke, H. C. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02623-1 · Cited by 23

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine

Ford, J. H., Ye, W., Ayer, D. W., Mi, X., Bhandari, S., Buse, D. C., & Lipton, R. B. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00552-4 · Cited by 24

Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study

Chowdhury, D., Tomar, A., Deorari, V., Duggal, A. K., Krishnan, A., & Koul, A. (2023) · Cephalalgia · doi:10.1177/03331024221143541 · Cited by 22

Pharmacological interventions for prophylaxis of vestibular migraine

Webster, K. E., Dor, A., Galbraith, K., Kassem, L. H., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015187.pub2 · Cited by 22

Migrende Yaşam Kalitesinin Değerlendirilmesi

Karlı, N., & Taşkapılıoğlu, Ö. (2013) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y7310 · Cited by 22

Headache-Specific Locus of Control and Migraine-Related Quality of Life: Understanding the Role of Anxiety

Grinberg, A. S., & Seng, E. K. (2016) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9587-2 · Cited by 22

The validation of a new comprehensive headache-specific quality of life questionnaire

Manhalter, N., Bozsik, G., Palásti, Á., Csépány, É., & Ertsey, C. (2012) · Cephalalgia · doi:10.1177/0333102412447702 · Cited by 22

Assessing Health-Related Quality of Life in Patients with Migraine

Becker, W. J. (2002) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000189x · Cited by 22

A real‐world, observational study of erenumab for migraine prevention in Canadian patients

Becker, W. J., Spacey, S. D., Leroux, É., Giammarco, R. A., Gladstone, J. P., Christie, S. N., Akaberi, A., Power, G. S., Minhas, J. K., Mancini, J., et al. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14291 · Cited by 21

Toward an Epidemiology of Refractory Migraine: Current Knowledge and Issues for Future Research

Lipton, R. B., & BIGAL, M. E. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01131.x · Cited by 21

Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME ( US ) study

Ashina, S., Muenzel, E. J., Nicholson, R. A., Zagar, A. J., Buse, D. C., Reed, M. L., Shapiro, R. E., Hutchinson, S. L., Pearlman, E. M., & Lipton, R. B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14729 · Cited by 21

Whites and African-Americans in Headache Specialty Clinics Respond Equally Well to Treatment

Heckman, B., Holroyd, K. A., Tietjen, G. E., O'donnell, F., Himawan, L. K., Utley, C., Watakakosol, R., & Stillman, M. J. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01785.x · Cited by 21

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study

Buse, D. C., Muenzel, E. J., Zagar, A. J., Mehrabadi, A. S., Shapiro, R. E., Kim, G., Ashina, S., Nicholson, R. A., & Lipton, R. B. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14925 · Cited by 19

Evaluation and Registration of Adverse Events in Clinical Drug Trials in Migraine

Tfelt‐Hansen, P. C., Bjarnason, N. H., Dahlöf, C. G. H., Derry, S., Loder, E., & Massiou, H. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01600.x · Cited by 18

Exploring the Relationship Between Maternal Migraine and Child Functioning

Fagan, M. A. (2003) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2003.03205.x · Cited by 18

Race, psychiatric comorbidity, and headache characteristics in patients in headache subspecialty treatment clinics

Heckman, B. D., Merrill, J. C., & Anderson, T. (2012) · Ethnicity and Health · doi:10.1080/13557858.2012.682219 · Cited by 16

Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study

Matharu, M. S., Katsarava, Z., Buse, D. C., Sommer, K., Reed, M. L., Fanning, K. M., & Lipton, R. B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14753 · Cited by 17

The PROMISE Study: PROphylaxis of MIgraine with SEglor?? (Dihydroergotamine Mesilate) in French Primary Care

Pradalier, A., Lantéri‐Minet, M., G�raud, G., Allain, H., Lucas, C., & Delgado, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00009 · Cited by 16

Quality of Life and Locus of Control of Migraineurs

Allen, L. L. (1999) · doi:10.31979/etd.xkdc-g4y8 · Cited by 16

Comparative Effectiveness of Pharmacologic Treatments for the Prevention of Episodic Migraine Headache: A Systematic Review and Network Meta-analysis for the American College of Physicians

Damen, J. A., Yang, B., Idema, D. L., Vernooij, R. W. M., Veld, L. F. H. I. ’., Kusters, M. P. T., Spijker, R., van der Braak, K., Heus, P., Jenniskens, K., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-00315 · Cited by 16

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study

Boudreau, G., Finkelstein, I., Graboski, C. L., Ong, M., Christie, S. N., Sommer, K., Bhogal, M., Davidovic, G., & Becker, W. J. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.153 · Cited by 15

Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 st edition

Schwedt, T. J., Tassorelli, C., Silberstein, S. D., Szperka, C. L., Kurth, T., Pozo‐Rosich, P., Amin, F. M., Lipton, R. B., Dodick, D. W., Ashina, M., et al. (2022) · Cephalalgia · doi:10.1177/03331024221099035 · Cited by 15

Patient-Reported Outcomes for Migraine in the US and Europe: Burden Associated with Multiple Preventive Treatment Failures

Ford, J. H., Nichols, R., Ye, W., Tockhorn‐Heidenreich, A., Cotton, S. E., & Jackson, J. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s304158 · Cited by 14

CGRP Targeting Therapy for Chronic Migraine—Evidence from Clinical Trials and Real-world Studies

Wang, Y.-F., & Wang, S. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01056-4 · Cited by 13

Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task

Marti‐Marca, A., Vilà‐Balló, A., Xim Cerdá-Company, Ikumi, N., Torres‐Ferrús, M., Caronna, E., Gallardo, V. J., Alpuente, A., Torralba, M., Soto‐Faraco, S., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01618-w · Cited by 15

Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study

Evers, S., Dell’Agnello, G., Novick, D., Gonderten, H. S., Panni, T., & Pascual, J. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00589-3 · Cited by 13

More Than Meets the Eye: The Eye and Migraine—What You Need to Know

Digre, K. B. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000660 · Cited by 13

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine

Ford, J. H., Kurth, T., Starling, A. J., Ayer, D. W., Wietecha, L. A., Port, M. D., Rettiganti, M. R., & Ruff, D. D. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14013 · Cited by 13

Health‐related quality of life measures and psychiatric comorbidity in patients with migraine

Mula, M., Viana, M., Jauch, R., Schmitz, B., Bettucci, D., Cavanna, A. E., Strigaro, G., Tota, M. G., Israel, H., Reuter, U., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02636.x · Cited by 13

Quality of Care Measures for Migraine: A Comprehensive Review

Gagne, J. J., Leas, B. F., Lofland, J. H., Goldfarb, N. I., Freitag, F. G., & Silberstein, S. D. (2007) · Disease Management · doi:10.1089/dis.2007.103639 · Cited by 12

Non-pharmacological interventions for prophylaxis of vestibular migraine

Webster, K. E., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., van Vugt, V. A., & Burton, M. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015321 · Cited by 12

Neurological mechanism and treatment effects prediction of acupuncture on migraine without aura: Study protocol for a randomized controlled trial

Hong, J., Sun, J., Zhang, L., Tan, Z., Chen, Y., Chen, Q., Zhu, Y., Liu, Y., Zhu, L., Zeng, L., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.981752 · Cited by 12

Smile: First Observational Prospective Cohort Study of Migraine in Primary Care in France. Description of Methods and Study Population

Géraud, G., Valade, D., Lantéri‐Minet, M., Radat, F., Lucas, C., Vives, E., Joubert, J.-M., & Mekiès, C. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01489.x · Cited by 12

Role of the Workplace in Migraine Disease Management

Warshaw, L. J., Burton, W. N., & Schneider, W. (2001) · Disease Management & Health Outcomes · doi:10.2165/00115677-200109020-00004 · Cited by 12

A real‐world prospective observational study of eptinezumab in Asian patients with migraine

Zhao, Y. J., Ong, J. J. Y., Sonu, S. K., Dang, J., Ng, C. C., Herr, K. J., Bose, R., & Jion, Y. I. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14737 · Cited by 12

Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus

Tziakouri, A., Tsangari, H., & Michaelides, C. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.687697 · Cited by 11

Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study

Hirata, K., Komori, M., Ueda, K., Zagar, A. J., Kim, Y., Jaffe, D. H., Matsumori, Y., & Takeshima, T. (2023) · Drugs - Real World Outcomes · doi:10.1007/s40801-023-00368-0 · Cited by 10

The state of art on the use of patient reported outcomes in migraine

Alpuente, A., Torres‐Ferrús, M., Caronna, E., & Pozo‐Rosich, P. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001267 · Cited by 12

Health–related quality of life (HRQOL) and migraine

Apolone, G., & Mosconi, P. (2001) · The Journal of Headache and Pain · doi:10.1007/s101940170004 · Cited by 10

Migraine and quality of life: psychological considerations

Andrasik, F. (2001) · The Journal of Headache and Pain · doi:10.1007/s101940170001 · Cited by 10

[Tools for assessing patient perception of the impact of migraine].

Hasnaoui, A. E., Doble, A., & Af, G. (2006) · PubMed · Cited by 10

What does it mean to have migraine?

Becker, W. J., & Ware, J. E. (2000) · Neurology · doi:10.1212/wnl.55.5.610 · Cited by 10

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials

Silberstein, S. D., Diener, H., Dodick, D. W., Sommer, K., & Lipton, R. B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14743 · Cited by 11

Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study

Shapiro, R. E., Muenzel, E. J., Nicholson, R. A., Zagar, A. J., Reed, M. L., Buse, D. C., Hutchinson, S. R., Ashina, S., Pearlman, E. M., & Lipton, R. B. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00668-9 · Cited by 9

Eletriptan Treatment of Migraine in Patients Switching from Barbiturate-Containing Analgesics: Results from a Multiple-Attack Study

Martin, V. T., Loder, E., Taylor, K., Almas, M., & Hilliard, B. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00963.x · Cited by 9

Renin-Angiotensin-Aldosterone System and Migraine: A Systematic Review of Human Studies

Sassi, K. L. M., Martins, L. B., de Miranda, A. S., & Teixeira, A. L. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200129160136 · Cited by 9

Quality of life in migraine

Anand, K., & Sharma, S. (2007) · Drug Development Research · doi:10.1002/ddr.20207 · Cited by 9

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study

Seng, E. K., Muenzel, E. J., Shapiro, R. E., Buse, D. C., Reed, M. L., Zagar, A. J., Ashina, S., Hutchinson, S. L., Nicholson, R. A., & Lipton, R. B. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14886 · Cited by 8

Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatments

Kuruppu, D. K., Tobin, J. A., Dong, Y., Aurora, S. K., Yunes‐Medina, L., & Green, A. L. (2021) · BMC Neurology · doi:10.1186/s12883-021-02196-7 · Cited by 8

Randomized controlled trial on the effectiveness of a multicomponent intervention on migraine: A study protocol

Renjith, V., Pai, A. R., Radhakrishnan, K., Nayak, B. S., Devi, E. S., Ladd, E., & George, A. (2017) · Journal of Advanced Nursing · doi:10.1111/jan.13478 · Cited by 7

Functioning of Women with Migraine Headaches

Talarska, D., Zgorzalewicz-Stachowiak, M., Michalak, M., Czajkowska, A., & Hudaś, K. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/492350 · Cited by 7

Clinical Investigation of Medicinal Products for the Treatment of Migraine

Kilminster, S. G., Dowson, A. J., & Ellender, D. (2003) · International Journal of Pharmaceutical Medicine · doi:10.1097/00124363-200317030-00002 · Cited by 7

Psychosocial headache measures in Caucasian and African American headache patients: Psychometric attributes and measurement invariance

Heckman, B. D., Berlin, K. S., Watakakosol, R., & Pierre, V. S. (2010) · Cephalalgia · doi:10.1177/0333102410372429 · Cited by 7

The Headache Impact Test?? and the Short Pain Inventory??

Kilminster, S. G., Dowson, A. J., & Bundy, M. (2003) · International Journal of Pharmaceutical Medicine · doi:10.1097/00124363-200317010-00008 · Cited by 7

Measuring headache day severity using multiple features in daily diary designs

McGinley, J. S., Houts, C. R., Wirth, R. J., & Lipton, R. B. (2021) · Cephalalgia · doi:10.1177/03331024211033829 · Cited by 6

Pharmacological interventions for prophylaxis of vestibular migraine

Webster, K. E., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., van Vugt, V. A., & Burton, M. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015187 · Cited by 6

Pharmacological interventions for acute attacks of vestibular migraine

Webster, K. E., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., van Vugt, V. A., & Burton, M. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015322 · Cited by 6

Quality of life and its predictors among patients with migraine in Qassim region, Saudi Arabia: a cross-sectional study

Almosaiteer, S. A., Rabbani, U., Alharbi, B. A., & Aldukhayel, A. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00507-4 · Cited by 6

Migraine co-existing tension-type headache and neck pain: Validation of questionnaires

Krøll, L. S., Hammarlund, C. S., Jensen, R., & Gard, G. E. (2015) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2015.03.001 · Cited by 6

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study

Lipton, R. B., Láinez, M. J. A., Ahmed, Z. A., Vallarino, C. R., Novick, D., Vincent, M. B., Viktrup, L., & Robinson, R. L. (2025) · Headache The Journal of Head and Face Pain · doi:10.1111/head.15045 · Cited by 5

Acupuncture for Migraine Without Aura and Connection-Based Efficacy Prediction

Zhang, X., Chen, Q., Liu, Y., Li, J., Nie, L., Miao, Q., Fu, F., Lyu, T., Tan, Z., Kong, Y., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.55454 · Cited by 7

Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial

Jönsson, L., Régnier, S. A., Kymes, S. M., Awad, S. F., Talon, B., Lee, X. Y., & Goadsby, P. J. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2219898 · Cited by 5

Validity, reliability, and sensitivity to change of the Thai version of the Migraine-Specific Quality of Life Questionnaire version 2.1

Asawavichienjinda, T., Vorasayan, P., Noiwatanakul, J., & Phanthumchinda, K. (2017) · Asian Biomedicine · doi:10.1515/abm-2018-0005 · Cited by 5

The prevalence of migraine headache among the general population and its impact on quality of life in Tabuk city, Saudi Arabia

Alatawi, A. M., Moria, H. A., Alharfy, A. A. N., Alotaibi, J. T. A., Alyami, M. A. M., Alzahrani, A. M. M., Albalwi, Z. S., & Albalawi, M. B. G. (2023) · Medical Science · doi:10.54905/disssi/v27i131/e48ms2692 · Cited by 5

Interictal burden, not ictal burden, drives work productivity impairment in headache disorders: insights from a Japanese cross-sectional study

Katsuki, M., Matsumoto, N., Matsumori, Y., Tatsumoto, M., Suzuki, K., Shimazu, T., Huerta, M. Á., Sato, D., Kikugawa, K., Kamado, S., et al. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-026-02284-4 · Cited by 6

Efficacy of onabotulinumtoxinA treatment in episodic migraine

Al-Hashel, J. Y., Alroughani, R., AlMojel, M., & Ahmed, S. F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1459767 · Cited by 4

Migraine Management in Japan: Current Approaches and Science Narrative Including an Evidence-based Review

Takeshima, T., Kikui, S., & Danno, D. (2024) · Internal Medicine · doi:10.2169/internalmedicine.4846-24 · Cited by 4

Cross‐Sectional Evaluation of the Psychometric Properties of the Headache‐Specific Locus of Control Scale in People With Migraine

Grinberg, A. S., & Seng, E. K. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13485 · Cited by 4

Mapping between headache specific and generic preference-based health-related quality of life measures

Khan, K., Mistry, H., Matharu, M. S., Norman, C., Petrou, S., Stewart, K., Underwood, M. R., & Achana, F. A. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01762-y · Cited by 4

Improvement in Health-Related Quality of Life with Rizatriptan 10mg Compared with Standard Migraine Therapy

Gerth, W. C., Ruggles, K. H., Stark, S. R., Davies, G., & Santanello, N. C. (2001) · Clinical Drug Investigation · doi:10.2165/00044011-200121120-00008 · Cited by 4

Assessment and management of disability in chronic daily headache

Pryse-Phillips, W. E. M. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0075-7 · Cited by 4

Perception de l??impact de la migraine par le patient: les outils de mesure

Hasnaoui, A. E., Doble, A., & Gaudin, A.-F. O. (2006) · CNS Drugs · doi:10.2165/00023210-200620001-00005 · Cited by 4

Unmet treatment needs in migraine: Results of the OVERCOME (US) study

Hutchinson, S. L., Johnston, E., Nicholson, R. A., Reed, M. L., Buse, D. C., Zagar, A. J., Kim, G., Muenzel, E. J., Pearlman, E. M., & Lipton, R. B. (2026) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70043 · Cited by 3

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults

Pringsheim, T. M., Smith, D. B., Tanveer, S., Becker, W. J., Burch, R. C., Cooke, L., Fenton, T., Fletcher, J. J., Perue, G. G., Hershey, A. D., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218112 · Cited by 3

Patient-reported outcomes related to migraine burden among patients treated with standard-of-care preventive medications or calcitonin gene-related monoclonal antibodies: a United States and Europe cross-sectional survey

Varnado, O. J., Jackson, J., Scharf, L., Kim, G., & Cotton, S. E. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2427884 · Cited by 3

Qualitative Analysis of Single-Site Headache Surgery

Israel, J. S., Gutierrez-Meza, D., Albano, N. J., Smith, J. P., Abd-Elsayed, A. A., Schwarze, M. L., Macdonald, C. L., & Afifi, A. M. (2021) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000002828 · Cited by 3

Estimation of the density of veins from susceptibility-weighted imaging by using Mamdani fuzzy-type rule-based system. Investigating the neurovascular coupling in migraine

López, R. G., Aymerich, F. X., Alberich, M., Caronna, E., Gallardo, V. J., Pozo‐Rosich, P., Rovira, À., & Pareto, D. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103489 · Cited by 3

Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraine

Chen, P., Karlsson, M. O., Ueckert, S., Pritchard‐Bell, A., Hsu, C., Dutta, S., & Ahamadi, M. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13048 · Cited by 3

Patient Reported Outcome Measures (PROMs) in Migraine and Headache

Buse, D. C., & Lipton, R. B. (2023) · Headache · doi:10.1007/978-3-031-25938-8_4 · Cited by 2

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study

Ailani, J., Okonkwo, R. I., Johnston, E., Hochstetler, H. M., Martinez, B., Zagar, A. J., Nicholson, R. A., Vargas, B. B., Muenzel, E. J., & Lipton, R. B. (2026) · Headache The Journal of Head and Face Pain · doi:10.1111/head.70014 · Cited by 2

The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study

Lipton, R. B., Martinez, B., Buse, D. C., Mehrabadi, A. S., Zagar, A. J., Cohen, F., Shapiro, R. E., Hoyt, M. L., Sait, A., Nicholson, R. A., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03428-9 · Cited by 2

Topo–kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report

Pini, L. A., Guidetti, G., Brovia, D., Pontremoli, P., & Sarchielli, P. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0248-0 · Cited by 2

Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis

Ailani, J., Andrews, J. S., Tockhorn‐Heidenreich, A., Wenzel, R. G., & Rettiganti, M. R. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02233-y · Cited by 2

PND26 VALIDATING USE OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 (MSQ) ACROSS MIGRAINE DISORDERS

Elson, C., Maglinte, G., Rendas‐Baum, R., DeRosa, M., Yang, M., & Varon, S. (2010) · Value in Health · doi:10.1016/s1098-3015(10)72688-7 · Cited by 2

A New Instrument to Assess the Long‐term Quality of Life Effects From Migraine: Development and Psychometric Testing of the MSQOL

Wagner, T. H., Patrick, D. L., Galer, B. S., & Berzon, R. A. (1996) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1996.3608484.x · Cited by 93

Development of a Brief 24‐Hour Migraine‐Specific Quality of Life Questionnaire

Hartmaier, S. L., Santanello, N. C., Epstein, R. S., & Silberstein, S. D. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3506320.x · Cited by 79

Validity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1)

Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00030.x · Cited by 299

Validation of a New Quality of Life Questionnaire for Acute Migraine Headache

Santanello, N. C., Hartmaier, S. L., Epstein, R. S., & Silberstein, S. D. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3506330.x · Cited by 83

Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment

Cole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 101